The most relevant human cancers in this context are melanoma, non-small cell lung cancer (NSCLC), ovarian cancer, gastric cancer, and colorectal cancer, where high levels of CXCL9/CXCL10 indicate favorable prognosis and low levels poor prognosis (13–19). This evidence concerns the gene CXCL10 and cancer.